Leerink Partners
North America, Massachusetts, United States, Boston
Description
Describes equity research, investment banking, and asset management services.
Investor Profile
Leerink Partners has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 6% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (53%)
- Series C (35%)
- Series Unknown (6%)
- Series A (6%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Genetics
- Biopharma
- Oncology
- Pharmaceutical
- Life Science
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Leerink Partners frequently co-invest with?
What are some of recent deals done by Leerink Partners?
Find More Investors Like Leerink Partners
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
